Access
To read this story in full you will need to login or make a payment (see right).
Letter
Nature 446, 690-694 (5 April 2007) | doi:10.1038/nature05656; Received 5 December 2006; Accepted 2 February 2007; Published online 18 March 2007
There is a Corrigendum (12 February 2009) associated with this document.
nature jobs
Senior Scientific Manager / Chief Scientific Manager for Metabolic Disorder and Cardiavascular Area In Vivo Pharmacology / Biology
- Syngene International
- Bangalore, Karnataka 560099 India
System Engineer (Simulation and Modelling)
- Praj Matrix - Praj Industries Ltd
- Pune, Maharashtra Pune-411021 India
Nuclear cytokine-activated IKK
controls prostate cancer metastasis by repressing Maspin
Jun-Li Luo1, Wei Tan1, Jill M. Ricono2, Olexandr Korchynskyi1, Ming Zhang3, Steven L. Gonias2, David A. Cheresh2 & Michael Karin1
- Laboratory of Gene Regulation and Signal Transduction, Department of Pharmacology and Cancer Center, School of Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093-0723, USA
- Department of Pathology and the Moores Cancer Center, University of California, San Diego, La Jolla, California 92093-0803, USA
- Baylor College of Medicine, Department of Molecular and Cellular Biology, One Baylor Plaza, Houston, Texas 77030, USA
Correspondence to: Michael Karin1 Correspondence and requests for materials should be addressed to M.K. (Email: karinoffice@ucsd.edu).
Abstract
Inflammation enhances tumour promotion through NF-
B-dependent mechanisms1. NF-
B was also proposed to promote metastatogenesis through epithelial–mesenchymal transition2. Yet a mechanistic link between inflammation and metastasis is missing. We identified a role for I
B kinase
(IKK
), activated by receptor activator of NF-
B (RANK/TNFRSF11A), in mammary epithelial proliferation during pregnancy3. Owing to similarities between mammary and prostate epithelia, we examined IKK
involvement in prostate cancer and its progression. Here we show that a mutation that prevents IKK
activation slows down CaP growth and inhibits metastatogenesis in TRAMP mice, which express SV40 T antigen in the prostate epithelium4. Decreased metastasis correlated with elevated expression of the metastasis suppressor Maspin5, the ablation of which restored metastatic activity. IKK
activation by RANK ligand (RANKL/TNFSF11) inhibits Maspin expression in prostate epithelial cells, whereas repression of Maspin transcription requires nuclear translocation of active IKK
. The amount of active nuclear IKK
in mouse and human prostate cancer correlates with metastatic progression, reduced Maspin expression and infiltration of prostate tumours with RANKL-expressing inflammatory cells. We propose that tumour-infiltrating RANKL-expressing cells lead to nuclear IKK
activation and inhibition of Maspin transcription, thereby promoting the metastatic phenotype.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Evidence that bone morphogenetic protein 4 has multiple biological functions during kidney and urinary tract developmentKidney International Original Article
A novel knock-in prostate cancer model demonstrates biology similar to that of human prostate cancer and suitable for preclinical studiesMolecular Therapy Original Article
See all 25 matches for Research
